Should regulators block CVS from buying Aetna?
A proposed health-care merger raises difficult antitrust questions
AMERICA has a competition problem. Market concentration has risen in more than three-quarters of industries since the late 1990s. Concentration has led to higher profits and higher returns for shareholders at the expense of consumers. Antitrust authorities have become more supine: between 1970 and 1999, regulators brought an average of 16 cases a year in order to prevent big firms from becoming even bigger; between 2000 and 2014, that number fell below three.
This article appeared in the Leaders section of the print edition under the headline “Prescription debate”
From the November 4th 2017 edition
Discover stories from this section and more in the list of contents
Explore the editionDiscover more
Lessons from the failure of Northvolt
Governments blew billions on a battery champion. Time to welcome foreign investors instead
How to make a success of peace talks with Vladimir Putin
The key is robust security guarantees for Ukrainians
Javier Milei: “My contempt for the state is infinite”
Argentina’s president is idolised by the Trumpian right. They should get to know him better
Tariff threats will do harm, even if Donald Trump does not impose them
The risk of a trade war is uncomfortably high
Peace in Lebanon is just a start
Donald Trump must build on Joe Biden’s belated success
From Nixon to China, to Trump to Tehran
Iran is weak. For America’s next president that creates an opportunity